New York State Common Retirement Fund’s Orchestra BioMed OBIO Stock Holding History

New York State Common Retirement Fund’s Portfolio OBIO Stock Details OBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$88K	Buy	+20,400	New	+$83.4K	﹤0.01%	2763
2025 Q2	–	Sell	-3,623	Closed	-$15.5K	–	3296
2025 Q1	$15.5K	Hold	3,623	–	–	﹤0.01%	3017
2024 Q4	$14.5K	Hold	3,623	–	–	﹤0.01%	3088
2024 Q3	$18.6K	Hold	3,623	–	–	﹤0.01%	3049
2024 Q2	$29.5K	Sell	3,623 -579	-14%	-$3.35K	﹤0.01%	3181
2024 Q1	$22.1K	Buy	4,202 +579	+16%	+$3.92K	﹤0.01%	3130
2023 Q4	$33.1K	Sell	3,623 -7,931	-69%	-$54.1K	﹤0.01%	3086
2023 Q3	$101K	Buy	11,554 +154	+1%	+$1.03K	﹤0.01%	2721
2023 Q2	$79.8K	Buy	+11,400	New	+$173K	﹤0.01%	3003

Other funds holding OBIO

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

New York State Common Retirement Fund's OBIO Position: Q2 2026 in Review

New York State Common Retirement Fund opened a new position in Orchestra BioMed (OBIO) in Q2 2026: 20,400 shares worth $88K. The stake represents ﹤0.01% of the portfolio and ranks #2763 among its holdings. This is a return to the name: New York State Common Retirement Fund previously reported a position in OBIO as recently as Q1 2025.

New York State Common Retirement Fund first reported a position in OBIO in Q2 2023 and has held it in 9 quarters since. The position peaked at $101K in Q3 2023. 77 funds tracked by Wall St. Rank hold OBIO as of Q2 2026.

New York State Common Retirement Fund held 20,400 shares of Orchestra BioMed worth $88K as of Q2 2026.
Orchestra BioMed was a new New York State Common Retirement Fund position in Q2 2026.
Orchestra BioMed made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2763 holding.
New York State Common Retirement Fund first reported a position in Orchestra BioMed in Q2 2023 and has held it in 9 quarters since.
New York State Common Retirement Fund's Orchestra BioMed position peaked at $101K in Q3 2023.
77 funds tracked by Wall St. Rank held Orchestra BioMed as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.